In this "column-batch" method for separating the MB and BB isoenzymes of creatine kinase and the LD1 isoenzyme of lactate dehydrogenase,one can, alternatively, separate MB from BB or obtain a combined fraction containing MB, BB, and LD1. The principal advantage is that the resulting fractions are twofold as concentrated as was the applied sample.
MaterIals and Methods

Sample buffer: 2-[Bis(2-hydroxyethyl)aminoj-2-(hydroxy-
Columns. The columns consist of SMI (Scientific Manufacturing Industries, Emeryville, CA 94608) G pipet tips fitted with either porous polyethylene ifiter discs (product code QS-6ED; Isolab Inc., Akron, OH 44321) or with filter discs from a standard pediatric Filter Sampler (Porex Medical Inc., Fairburn, GA 30213). Alternatively, 1-or 2-mL disposable syringes may be used as columns. The internal diameter of the column should be about 6 mm, the height at least 55 mm. The top of the column should have a rim, which can be used to support it in a tube so that the end of the column is at least 15 mm above the bottom of the tube. This arrangement should be rugged enough to withstand centrifugation at 3000 rpm. The columns can either be discarded after a single use or re-used until the porous ifiter becomes clogged with fines, usually after 10-15 uses.
Column preparation.
Using an SMI G pipet fitted with a G tip that has been modified by removing the shoulder with a razor or scalpel (otherwise, resin will accumulate on the shoulder and pipetting will be impossible), dispense 1 mL of well-mixed resin suspension into each column. If the flow does not begin within a few minutes, apply a slight positive pressure at the top with a rubber bulb, to initiate flow. Once the column has emptied of fluid, the resin height should be 23 to 25 mm, corresponding to a volume of about 0.6 mL.
Although the method is not too sensitive to column deviations, if the bed height and volume are not correct the resin suspension is easily adjusted after settling by adding or removing appropriate amounts of buffer.
Procedure.
Dilute 500 j.L of serum with an equal volume of sample buffer, transfer 800 pL of this dilution to a column, and allow it to flow through the column by gravity.
When flow is complete (about 5 mm), fill the column with sample buffer and allow the column to drain. Repeat this wash once. Place the drained columns in 10 x 75 mm tubes, as described above, and centrifuge at about 3000 rpm for 2 mm in a conventional swinging-bucket head about 15-30 cm in diameter. The total volume emerging from the column in the above steps is called the "wash-through fraction"; except in developmental procedures, it usually is discarded. Apply to each column 200 pL of MB elution buffer, place the columns into clean tubes, and centrifuge at low speed (about 300-500 rpm) for 2 mm. Increase the speed to 1000 rpm for 2 mm, then to 3000 rpm for a final 2 miii. The effluent in the tube contains the MB fraction. If the BB fraction is then to be collected, proceed to rinse the column once with the sample buffer, either by gravity flow or centrifugation, then follow with 200 L of BB elution buffer and centrifuge as for MB.
If a combined MB and BB fraction is to be obtained, then proceed as for MB fraction, substituting the BB elution buffer.
Once the specimen has been applied to the column, either procedure requires about 30 mm to complete. With repeated stirrings of the resin suspension, fines will appear after a few weeks of daily use and will slow down the gravity flow. These fines should be decanted and fresh sample buffer added to restore the ratio of settled bed volume to above-bed buffer volume that yields columns of correct geometry.
CK and LD measurement.
We measured CK activity with CK-NAC reagent (Biodynamics/BMC, Indianapolis, IN 46250), whose formulation is based on the Scandinavin Recommendations (4). LD activity was measured with Biodynamics/BMC LD (pyruvate-to-lactate) reagent. For both, we used a Rotochem Ha centrifugal analyzer at 37#{176}C.
Electrophoresis.
For electrophoresis, we used agarose plates (Corning, Palo Alto, CA 94306) as previously described (3), except that the CK-NAC reagent was used throughout to develop the visible isoenzyme patterns.
Immunoinhibition.
For this, we used CK-MB (SmithKline
Instruments,
Inc., Sunnyvale, CA 94086) and Monotest CK-MB (BiodynamicsfBMC), each according to the manufacturer's directions.
Results
Method development.
Conditions were sought that would yield maximum activity of MB, with no contamination with MM by reason of overflow. We considered it possible to obtain an MB fraction relatively free of BB. (No attention was given initially to LD isoenzymes.) Figure 1 shows the retention of these CK isoenzymes at different starting pH. Below pH 6.5, no MM is retained; above pH 6.2, MB and BB retention increase only very gradually. These data led us to select 6.3-6.4 as the optimum starting pH to use for the adsorption.
Column variables-primarily resin volume, bed height, and elution volume-were selected empirically on the basis of the the experimental data shown in Figure 2 . Curve A shows the relation between increasing colunm bed and retention of MB from a 400-L sample containing 350 U/L. Curve B shows the corresponding elution maximum activities and, by reference to the diagonal third axis, the cumulative elution volume required to obtain maximum activity.
Thus curve
That this is useful in selecting separation 10-12 UIL, where retention and recovery rapidly approach conditions is evident from Figure 2 . For example, use of a 100%. This means that the method is only semiquantitative resin volume of 0.6 mL with a bed height of 24mm (volume for MB activities below 12 UIL, but it also increases the height = 14) results in retention of only about half of the method's sensitivity and precision at activities where most applied activity (Curve A), which is eluted in 0.2 mL, half methods are both insensitive and imprecise. Indeed, it is the applied volume. Thus the activity per unit volume of possible to correct for the increased retention at < 12 U/L. eluate is doubled-in effect, restoring it to 100% of that in Figure 5 shows the effect of ionic strength on elution of MB. the original sample. If we had selected a resin volume of 1
It also shows that the sodium and magnesium salts in mL, a bed height of 14 mm would be required to obtain the equivalent molar concentrations are not interchangeable; same results. Thus, retention clearly depends on bed volume evidently the magnesium ion facilitates elution. and bed height, but it is equally clear that this dependence
Electrophoresis.
Electrophoretic examination of the eluted is not critical:
there is little change in eluted activity MB fraction, BB fraction, and combined MB-BB fraction on between 10 and 20 (mL x mm), and so results can be agarose revealed that none of these contained detectable reproducible without column preparation being critical.
MM, even when it was applied in concentrations as great as This volume-bed-height relationship was found empirically 60 000 U/L. The MB fraction consisted virtually exclusively to .be valid insofar as we examined it in developing this procedure.
As expected for a batch method, increasing the amount of resin results in increased retention of applied activity, but it also results in a less-concentrated eluate because of the greater elution volume. Thus, there are optimum conditions. Under the conditions described above, the effects of increasing sample volume on MB retention and recovery are illustrated in of MB, containing no more than 5% BB, even when half the activity in the applied sample was BB or when the BB activity was 240 U/L. The BB fraction contained no more than 15% MB when the applied sample contained 80% MB, or 310 U of MB per liter. In terms of concentration, the combined MB-BB fraction accounted for virtually 100% of the MB and 184% of the BB per milliliter of original sample.
LI) isoenzymes.
We wondered how the LD isoenzymes in serum would partition under these conditions. Examination of the above-described fractions revealed that the fraction containing the MB also contained LD isoenzymes, the proportions being about 2% LD3, 35% LD2, and 65% LD1. Lactate dehydrogenase in the BB fraction consisted of 2% LD2 and 98% LD1. That in the combined MB-BB fraction consisted of <1% LD3, 8% LD2, and 92% LD1. These percentages represent the distribution of LD isoenzymes in these fractions, not the analytical recovery of these isoenzymes. These percentage distributions were remarkably constant for the 42 samples so examined. Thus, it became evident that the combined MB-BB fraction was also potentially useful for measuring LD1. Electrophoresis and Roche Isomune LD1 measurements of the "wash-through" fraction indicated that all LD1 was retained on the column. Comparison with Roche Isomune LD1 indicated that the combined fraction yielded virtually 100% analytical recovery and a twofold concentration. 
Correlations.
A comparison of MB values as
Precision.
A representative 10 replicate analysis for MB at 12 U/L yielded a CV of 28%; at 23 U/L, 17%; at 56 UIL, 8%; and at 115 UIL, 4%. Much of this variation reflects limitations of the measurement and not of the separation. Analysis time was only 2 mm. Although we feel that a variation of ±4 U/L is acceptable, some analysts may wish to improve the precision by using longer analysis times. The CV at 12 U/L can be improved to 8% by using a 5-mm analysis. Overall variation (CV) during four years for control sera containing 40 U and 100 U of MB per liter was 11% and 6%, respectively. For LD1 the CV for replicate analyses was 6% at 140 U/L. Overall variation with control sera during four years indicates a CV of 8% at 140 U/L. These overall variations are those to be expected in actual use. They include contributions to variation from changes in con irol sera, columns, technicians, etc.
Replicate samples taken through the procedure up to adsorption on the column and then stored at 4#{176}C for extended periods yielded a CV of <5% at 120 U/L for assays done during more than four years. Evidently, adsorption on an ion-exchanger may be a useful method of preserving isoenzymes for valid long-term storage.
Discussion
This procedure, in continuous use in this laboratory for over four years, has proven to be reliable, easily reproducible, and remarkably trouble-free. The option that we use currently is the collection of the combined MB-BB fraction, because the MB in this fraction is consistently about 48-56% accounted for, and, because this activity is contained in half of the applied volume, the corrected analytical recovery is 96 to 112%. All of the applied LD1 appears, in this same fraction, again in a volume corresponding to half the volume of the original sample. Although, as with related methods (5,6), the MB and LD1 isoenzymes are not perfectly resolved into this fraction-it contains BB, if present, and about 8 to 10% LD2 and LD3-this does not substantially detract from the clinical value of these two indicators of cardiac daniage, because, in our experience in clinical situations, the incidence of measurable amounts of BB in serum is too low for it to be a substantial source of error. Further, we have experienced no problem in identifying BB, because, when it is present, we have found it usually is in relatively high percentages of the total CK-and the doubling in the concentration of BB in the eluted fraction makes it still more conspicuous. When BB is present, as with prostatic carcinoma, the combined MB-BB activity almost always exceeds 30% of the total CK activity.
Although the convenience of quantitatively obtaining both MB and LD1 from the same fraction makes this option attractive, some laboratories may prefer to use the MB-only option, and this may be preferable with some patient populations (8) if there is a higher-than-expected incidence of measurable BB.
The ability to obtain concentrated fractions directly makes this method unique among ion-exchange methods for MB separation. In related methods, the MB-containing fractions are diluted by three-to 15-fold (7). Even current iminunoinhibition methods, because they are B-subunitspecific, measure only 50% of the MB. This uniqueness is the result of the selection of conditions that permit a small column to perform in a batch mode rather than the conventional column mode. Regardless of how much MM is applied, none is retained. And even though not all the MB is retained, under the described conditions this is compensated for, because the retained MB is eluted in a volume corresponding to half of that applied.
Considerable data have been accumulated on the clinical use of this method, and some of it has already been presented elsewhere (9-11). Figure 6 summarizes the distribution of results obtained with a non-MI and an MI popula- CK-MBha/she attained in a series of (usually) three determinations. The myocardial infarct (Ml)populationis 58% ofthe total tion. Of this combined population only 3% (18 patients) had detectable BB, an incidence higher than the 1.9% reported by Wu and Bowers (12). Of these 18 patients$ 12 had twofold-concentrated BB that exceeded 30% of total CK, four had both MB and BB in significant quantities and were considered consistent with myocardial infarct, and the other two were genuine ambiguities. Any twofold-concentrated BB amounting to less than 6 U/L was ignored. Details of the clinical picture seen on using this method will be presented.
We routinely
perform the combined fractionation on any specimen submitted for CK assay that has total CK exceeding 120 U/L (in our laboratory 180 UIL is considered the upper limit of normal). 
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